Chemoinformaics analysis of 3-TRANS,9-CIS,12-CIS,15-CIS-OCTADECATETRAENOIC-ACID
Molecular Weight | 442.728 | nRot | 4 |
Heavy Atom Molecular Weight | 392.328 | nRig | 22 |
Exact Molecular Weight | 442.381 | nRing | 4 |
Solubility: LogS | -6.75 | nHRing | 0 |
Solubility: LogP | 7.222 | No. of Aliphatic Rings | 4 |
Acid Count | 1 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 4 |
Atoms Count | 82 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 32 | No. of Aromatic Carbocycles | 0 |
nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 3 |
No. of Hydrogen atom | 50 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 30 | No. of Saturated Rings | 3 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
nHA | 1 | APOL | 85.0436 |
nHD | 1 | BPOL | 51.0284 |
QED | 0.444 |
Synth | 4.754 |
Natural Product Likeliness | 3.068 |
NR-PPAR-gamma | 0.502 |
Lipinski | Accepted |
Pfizer | Rejected |
GSK | Rejected |
Golden Triangle | Rejected |
Pgp-inh | 0.003 |
Pgp-sub | 0 |
HIA | 0.011 |
CACO-2 | -5.082 |
MDCK | 0.0000089 |
BBB | 0.213 |
PPB | 1.00575 |
VDSS | 0.936 |
FU | 0.0183232 |
CYP1A2-inh | 0.017 |
CYP1A2-sub | 0.511 |
CYP2c19-inh | 0.037 |
CYP2c19-sub | 0.965 |
CYP2c9-inh | 0.1 |
CYP2c9-sub | 0.879 |
CYP2d6-inh | 0.004 |
CYP2d6-sub | 0.221 |
CYP3a4-inh | 0.125 |
CYP3a4-sub | 0.564 |
CL | 16.107 |
T12 | 0.03 |
hERG | 0.005 |
Ames | 0.022 |
ROA | 0.184 |
SkinSen | 0.021 |
Carcinogencity | 0.04 |
EI | 0.031 |
Respiratory | 0.956 |
NR-Aromatase | 0.597 |
Antiviral | No |
Prediction | 0.658468 |